Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula
ICD-10 E09.352 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula.
E09.352 refers to diabetes mellitus that is induced by drugs or chemicals, characterized by the presence of proliferative diabetic retinopathy (PDR) and traction retinal detachment affecting the macula. Drug-induced diabetes can arise from various medications, including corticosteroids, antipsychotics, and certain chemotherapeutic agents. Proliferative diabetic retinopathy is a severe complication of diabetes, marked by the growth of new blood vessels in the retina, which can lead to vision loss. The traction retinal detachment occurs when these new vessels pull on the retina, causing it to detach from the underlying tissue, particularly affecting the macula, which is crucial for central vision. Management of this condition requires a multidisciplinary approach, including endocrinology for diabetes management and ophthalmology for retinal issues. Regular monitoring of HbA1c levels is essential to assess long-term glucose control, with targets typically set below 7% for most adults. Insulin therapy may be necessary to achieve glycemic control, especially in cases where oral hypoglycemics are ineffective due to the severity of the condition.
Detailed medication history, HbA1c levels, and diabetes management plan.
Patients presenting with new-onset diabetes due to medication, requiring insulin therapy.
Ensure clear documentation of the specific drug causing diabetes and its management.
Detailed retinal examination findings, including the extent of retinopathy and presence of traction detachment.
Patients with diabetes presenting with vision changes due to retinal complications.
Document the visual acuity and specific retinal findings to support the diagnosis.
Used during follow-up visits for diabetic retinopathy assessment.
Document visual acuity, retinal findings, and treatment plan.
Ophthalmologists should ensure thorough documentation of retinal examination.
Common medications that can induce diabetes include corticosteroids, certain antipsychotics, and some immunosuppressants. It is crucial to document the specific medication responsible for accurate coding.
